Abstract:Typical physiological characteristics of tumors, such as weak acidity, low oxygen content, and upregulation of certain enzymes in the tumor microenvironment (TME), provide survival advantages when exposed to targeted attacks by drugs and responsive nanomedicines. Consequently, cancer treatment has significantly progressed in recent years. However, the evolution and adaptation of tumor characteristics still pose many challenges for current treatment methods. Therefore, efficient and precise cancer treatments require an understanding of the heterogeneity degree of various factors in cancer cells during tumor evolution to exploit the typical TME characteristics and manage the mutation process. The highly heterogeneous tumor and infiltrating stromal cells, immune cells, and extracellular components collectively form a unique TME, which plays a crucial role in tumor malignancy, including proliferation, invasion, metastasis, and immune escape. Therefore, the development of new treatment methods that can adapt to the evolutionary characteristics of tumors has become an intense focus in current cancer treatment research. This paper explores the latest understanding of cancer evolution, focusing on how tumors use new antigens to shape their "new faces"; how immune system cells, such as cytotoxic T cells, regulatory T cells, macrophages, and natural killer cells, help tumors become "invisible", that is, immune escape; whether the diverse cancer-associated fibroblasts provide support and coordination for tumors; and whether it is possible to attack tumors in reverse. This paper discusses the limitations of targeted therapy driven by tumor evolution factors and explores future strategies and the potential of intelligent nanomedicines, including the systematic coordination of tumor evolution factors and adaptive methods, to meet this therapeutic challenge.

Advances in understanding tumor evolution

Darwinian Evolution and Tumor Ecosystem

Resolving tumor evolution: a phylogenetic approach

Cancer Evolution: A Means by Which Tumors Evade Treatment.

Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution

Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy

An Evolutionary Genetic Perspective on Cancer Biology

The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process

Cancer: Evolution Within a Lifetime

Cancer evolution: Darwin and beyond

Nongenetic evolution of the tumor: from challenges to new therapeutic opportunities

Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Characterizing the Ecological and Evolutionary Dynamics of Cancer

The Theory of Tumor Ecosystem

An evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation

Molecular Biology and Evolution of Cancer: From Discovery to Action

Tumor Evolution: A Problem of Histocompatibility

Spatial biology of cancer evolution

[Co-evolutionary analysis on strategy for therapy of spreading cancer]

Viewing Tumor Immunology by Means of Natural Selection Theory